Dr. Anthony Magliocco, Protean’s President & CEO will present at the 2nd Biomarker Insights Summit in New Orleans this April 8th 2022. The theme of this year’s summit is ‘Illuminating Tissue Biology in a Digital Era’
You can learn more about the event, or register for your free pass at the link below.
Protean will be at Synapse Summit in Tampa Florida this Thursday!
Stop by booth 106-11 to say hello, and learn more about how we are improving access to precision cancer testing for patients around the world.
Protean will present at the 4th Annual Best of Breast Cancer Conference as faculty Jan 22-23, 2022 in West Palm Beach, FL. Dr. Magliocco will participate as a panel member discussing diagnostics and treatments of challenging breast cancer cases.
- On Demand Video to be available soon.
Learn more about the conference & access the platform here:
www.totalhealthconferencing.com/bestofbreastcancer
Come visit Protean's booth at the San Antonio Breast Cancer Symposium, and learn how we can connect you to best in class precision oncology testing. Every test you need, in one place!
Synapse Orlando is the annual gathering for all of the doers, creators, innovators, thought leaders making Orlando one of the world’s fastest growing innovation communities and hottest destinations to live, work and play.
Stop by Protean’s table and say hello this Friday!
Digital Insights to Tumor Biology: Uncovering the Complexities of the Tumor Immune Microenvironment with Digital Pathology
Dr. Magliocco is giving a keynote lecture today at 1:45-2:25 PM ET on advanced in digital pathology with a focus on discovery and implementation of new cancer biomarkers.
Dr. Magliocco will be presenting an update on the remarkable advances in precision medicine and how they will impact the care and outcomes of cancer patients. He will focus on the importance of using new diagnostic testing services to better analyze each patients cancer and how this information is used to optimize the treatment. There will also be a discussion of the value of clinical trials.
Event will take place on Thurs Sep. 23rd at 2:55 pm ET
Register for the free event:
https://lifeomic.com/about/events/cancer-wellness-virtual-symposium/
Objectives of This Webinar:
Understand the impact of the precision oncology revolution on the practice of pathology and laboratory medicine
Review new technologies that will shape the future of laboratory medicine, including digital pathology, multi-omics, liquid biopsy and more
Discuss the data challenges and opportunities of integrating machine learning into pathology practice
Identify the major barriers to adoption and transformation of pathology
Listen to recording of webinar: https://register.gotowebinar.com#register/8637373438261374732
Join Dr. Magliocco, who has 30 years of experience in cutting-edge cancer treatment, to learn more about what a day-in-the-life of a pathologist looks like when using a digital pathology platform with a smooth, responsive viewer and an intuitive interface. Manage your workload, stay organized, and access information easier than ever before.
Event will be hosted by Proscia on Tuesday June 15, 11:00 AM EDT
For more information or to register, please visit:
https://proscia.com/future-ready/
Join Dr. Magliocco, who has 30 years of experience in cutting-edge cancer treatment, to learn more about biodiagnostics, precision tests, and treatments for breast cancer patients. Dr Magliocco will review some of the current testing technology that is available for cancer patients and be available to answer specific questions from the audience.
This program is conducted through Zoom. Register to receive a reminder, the evaluation and any resource materials or click the link to join. The meeting will take place between 9:00PM- 10:30 PM EDT.
Join Dr. Magliocco to learn more about the incredible advances in cancer precision treatments and advanced diagnostics. Free online zoom lecture, hosted by the Regina Public Library.
Open to all interested.
To Register please Visit:
http://rpl.libnet.info/event/4779695
The American College of Healthcare Executives are having a FREE virtual event : The Precision Medicine Virtual Panel featuring experts in precision medicine including Dr. Magliocco, Dr. Dasouki, Dr. Gibson and moderated by Dr. Walker Director of Genomics and Personalized Health at AdventHealth.
Open to all interested. Educational credits available.
To Register please Visit: achecf.org/upcoming-events
Dr. Anthony Magliocco, CEO of Protean BioDiagnostics, will be featured on the free podcast ‘Digital Pathology Today’ hosted by Pathologist, Dr. Joseph Anderson.
Digital Pathology Today is a new podcast all about the world of digital pathology. Each week, Dr. Anderson speaks with industry leaders, key academics, and top pathologists to discover the past, present and future of digital pathology.
Dr. Anthony Magliocco, CEO of Protean BioDiagnostics, will be presenting a free webinar sponsored by Proscia, on the topic of digital pathology.
In this 60 minute webinar, you will:
Recognize the return of going digital in terms of workflow, outcomes, and cost
Identify approaches and considerations for digital adoption, including technology requirements
Understand how early adopters have leveraged digital and AI to address growing pressures on their labs
Learn best practices for using digital pathology to support a remote workforce during these uncertain times and much more
Dr. Anthony Magliocco, CEO of Protean BioDiagnostics, will be presenting a webinar on our innovative framework for rapidly deploying the latest companion diagnostics.
In this webinar, you will learn more about
Protean’s proprietary, multi-omic, data-centric Oncology MAPS™ system and how the system creates an easy way for oncologists and patients to access the latest evidence-based diagnostics, guideline-driven therapeutics, and new clinical trials.
How QIAGEN’s bioinformatics team and Protean are working together to successfully deploy WES into clinical practice and give practitioners the knowledge to improve disease risk management and select treatment.
Protean’s goal of maintaining and managing genetic and other medical data for patients in MAPS™ system, which enables this complex genetic data to become both “future-protected” and an enduring legacy for the patient, and their family.
Protean BioDiagnostics will attend the 2020 Synapse Summit in Tampa FL.
This two day event will be focused on bringing together the community, starting meaningful dialogues, and connecting entrepreneurs, investors, corporations, service providers, governments, and more. The event will also include many talks, hands-on workshops, and dynamic panel discussions.
Email info@proteanbiodx.com to arrange appointments
Protean BioDiagnostics will attend this year’s Indiana Rural Hospital Association 2020 Public Policy Forum in Indianapolis. This one day event will be attended by the “C” Suite of the association membership which include some thirty-eight hospitals.
Email info@proteanbiodx.com to arrange appointments
Protean BioDiagnostics CEO and President, Dr Anthony Magliocco, will be presenting Protean BioDiagnostics disruptive and innovative approach to accelerating access to precision oncology to all using a fully integrated patient centric multi-omics approach at the 2020 Precision Medicine World Conference in Silicon Valley Jan 24.
Email info@proteanbiodx.com to arrange appointments
Representative from Protean BioDiagnostics will be attending GI ASCO this year to discuss opportunities for collaboration. Protean BioDiagnostics is an innovative biotechnology company focused on the acceleration of precision oncology using a unique integrated multiomics approach.
Email info@proteanbiodx.com to arrange appointments
Protean BioDiagnostics will be presenting at the 2019 Korean International Global Technology Cooperation Forum.
Dr. Magliocco, CEO of Protean BioDiagnostics, will be presenting at the international Global Technology Cooperation Forum in Seoul Korea on Dec 12-14 which is part of the K-Tech 2019 Exhibition.
Protean BioDiagnostics is an emerging leader in the provision of precision oncology diagnostic support products and an accelerator of data driven approaches to improve treatment and outcomes for cancer patients. Areas of expertise include diagnostic pathology, comprehensive genomic analysis, digital pathology, artificial intelligence, liquid biopsy and clinical trials. Protean BioDiagnostics also operates a CAP CLIA laboratory to facilitate the commercialization of cancer biomarkers to its extensive network of clients.
Dr. Magliocco and other members of the Protean Team will be available for consultations, networking and business meetings in Korea between Dec 7 and 15. Contact darlene.sica@proteanbiodx.com for appointments or more information.
Dr. Anthony Magliocco MD, President and CEO of Protean BiDiagnostics will be speaking at the 8th International Congress on Cancer Metastasis in San Fransisco on Oct 25-27.
The talk will explore novel uses of machine learning and analytic microscopy in the diagnosis and prognosis of cancer.
Join Anthony M. Magliocco, President and CEO of Protean BioDiagnostics, for a Dinner Symposium on Precision Medicine. The symposium will center on current and emerging biomarkers: science, technologies, and practicalities, and Dr. Magliocco will review the intricacies of the pre-analytical phase and explore variables that may impact the reliability of laboratory testing, including biomarker results.
To pre-register, please RSVP at 1-866-326-7600 from 8:30 AM – 5:00 PM EST, Monday-Friday using meeting ID 191004-NON-50355. Walk-ins are also welcome!
Protean BioDiagnostic’s CEO Dr. Anthony Magliocco MD will be speaking at the European Annual Meeting on Multiplex Histopathology, on September 12th at Montpellier.
The meeting is centered around the possibilities of Multiplex Histopathology in phenotyping and physiopathological mechanisms, and in aiding our understanding of major diseases.
Dr. Anthony Magliocco, the Protean BioDiagnostics CEO will be presenting an update webinar on current and emerging biomarkers in immuno-oncology, on September 5th.
Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers.
Some of the learning objectives of the webinar are : review of the immune system and cancer, current and Emerging predictive I-O biomarkers, and biomarker testing practicalities.
Dr. Anthony Magliocco MD, President and CEO Protean BiDiagnostics will be speaking at the Inspirata Executive Exchange. The meeting will center on practical advantages in cancer care and research, and will take place between July 31st and August 2nd 2019.
USF selects Protean BioDiagnostics for company showcase. Join CEO and Founder Dr. Anthony Magliocco on July 18 at 900AM as he presents the mission and vision of Protean BioDiagnostics to reimagine cancer pathology.
Dr Magliocco CEO and President of Protean BioDiagnostics will be a panelist discussing the impact of digital pathology on precision medicine diagnostics at the Precision Medicine Leaders Summit East in Philadelphia June 11 and 12
Protean BioDiagnostics has recently partnered with the AI technology leader Nucleai to comercialize advanced AI based diagnostics into the US pathology market with an initial target focus on improving quality of prostate cancer pathology diagnosis in urology practices